Workflow
泰恩康：Q3业绩符合预期，CKBAII期全部受试者入组
301263T&K(301263) 华安证券·2024-11-06 08:10

泰恩康（301263） 公司点评 Q3 业绩符合预期，CKBAII 期全部受试者入组 | --- | --- | --- | --- | |---------------------------------------------------------------------------------------------------------------------------------|---------|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...